Disintegration Tester Market Report 2026

The disintegration tester market size has grown strongly in recent years. It will grow from $109.69 billion in 2025 to $117.42 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to pharmacopoeial quality standards, growth of solid dosage drugs, manual testing limitations, regulatory compliance needs, expansion of pharmaceutical manufacturing.

The disintegration tester market size is expected to see strong growth in the next few years. It will grow to $153.65 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to automation in quality control labs, pharmaceutical outsourcing growth, smart laboratory adoption, regulatory stringency, demand for high-throughput testing. Major trends in the forecast period include growing demand for automated disintegration testers, increasing focus on pharmaceutical quality compliance, adoption of digitally controlled testing instruments, expansion of multi-station testing systems, rising use in contract manufacturing facilities.

The growth of the pharmaceutical industry is expected to drive the expansion of the disintegration tester market in the coming years. The pharmaceutical sector focuses on the research, development, production, and distribution of drugs and medications for the prevention, diagnosis, treatment, and cure of diseases. The industry’s expansion is fueled by factors such as an aging population, rising prevalence of chronic diseases, advancements in medical technology, improved healthcare access, and increasing awareness of health and wellness. A disintegration tester is a key instrument in the pharmaceutical sector, used to assess the time required for tablets, capsules, or other solid dosage forms to break down into smaller particles when exposed to specific fluids under controlled conditions simulating the human gastrointestinal tract. For example, in November 2025, the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental organization providing comparative data and policy insights, reported that retail pharmaceuticals accounted for about one-sixth of total health spending across OECD countries in 2023. The report further noted that per capita spending on retail pharmaceuticals averaged USD 766 (PPP-adjusted) among OECD members, with the United States recording the highest per capita expenditure at USD 1,713. Hence, the expansion of the pharmaceutical industry is propelling the growth of the disintegration tester market.

The rising prevalence of chronic diseases is also expected to drive the growth of the disintegration tester market. Chronic diseases are long-term conditions requiring continuous medical attention and can restrict daily activities. Their increasing incidence is mainly driven by aging populations, lifestyle changes, and risk factors such as obesity and sedentary habits. The disintegration tester market provides vital quality control instruments that ensure consistent and effective drug release for medications used to manage chronic conditions. For instance, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health institute, reported that chronic conditions are widespread across all adult age groups in the United States. Among adults aged 65 and older, over 90% have at least one chronic condition. In the midlife population (ages 35 to 64), more than three-quarters are affected by at least one chronic condition. Even among younger adults (ages 18 to 34), approximately 60% live with at least one chronic condition, highlighting the broad impact of chronic diseases across adulthood. Therefore, the increasing prevalence of chronic diseases is contributing to the growth of the disintegration tester market.

In May 2023, Verder Group, a Netherlands-based manufacturer of laboratory and analytical equipment, acquired ERWEKA GmbH for an undisclosed sum. Through this acquisition, Verder Group aims to create synergies that accelerate innovation, enhance service offerings for pharmaceutical customers, and advance its growth with state-of-the-art equipment. ERWEKA GmbH is a Germany-based manufacturer specializing in disintegration testers and laboratory equipment for the pharmaceutical industry.

Major companies operating in the disintegration tester market are Agilent Technologies Inc., MRC Group, Veego Instruments, Sotax Corporation, Labindia Analytical Instruments Private Limited, Kerone Engineering Solutions Ltd., Torontech Inc., Distek Inc., Koehler Instrument Company, Inc., Veego Instrument Corporation, Saintyco, Kinesis Inc., Copley Scientific Limited, Pharma Test Apparatebau AG, Yatherm Scientific, Charles Ischi AG, Pharmatron LLC, ATS Scientific Inc., Electrolab Group, Vedor Group.

Asia-Pacific was the largest region in the disintegration tester market in 2025. The regions covered in the disintegration tester market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disintegration tester market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the disintegration tester market by increasing costs of imported testing equipment, sensors, and electronic components. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported instruments. These tariffs raise capital expenditure. However, they encourage local instrument manufacturing and regional laboratory equipment suppliers.

The disintegration tester market research report is one of a series of new reports that provides disintegration tester market statistics, including disintegration tester industry global market size, regional shares, competitors with a disintegration tester market share, detailed disintegration tester market segments, market trends and opportunities, and any further data you may need to thrive in the disintegration tester industry. This disintegration tester market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A disintegration tester is a laboratory device primarily used in the pharmaceutical sector to determine the time required for tablets, capsules, or other solid dosage forms to break down into smaller particles when exposed to specific fluids, such as gastric or intestinal fluids, under controlled conditions. This instrument is essential for quality control and adherence to pharmacopeial standards, ensuring the drug’s efficacy and proper release of active ingredients.

The main types of disintegration testers include 2-station disintegration testers, 4-station disintegration testers, 6-station disintegration testers, and others. A 2-station disintegration tester is a pharmaceutical testing device featuring two testing stations. These instruments are distributed through multiple channels such as direct sales, distributors, and online retail, and are utilized in various applications including the pharmaceutical industry, cosmetics industry, food industry, and more.

The disintegration tester market consists of sales of manual disintegration tester, semi-automatic disintegration tester, and double basket Disintegration tester. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.